Confidence and psychosis: a neuro-computational account of contingency learning disruption by NMDA blockade.
Fabien Vinckier, Raphaël Gaillard, S Palminteri, L Rigoux, Alexandre Salvador, A Fornito, R Adapa, M O Krebs, M Pessiglione, P C Fletcher
Molecular Psychiatry June 9, 2015 DOI: 10.1038/mp.2015.73 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Placebo-controlled, double-blind, crossover functional MRI study Peer reviewed |
|---|---|
| Population | Healthy volunteers |
| Intervention | Ketamine |
| Topics | Ketamine |
| Keywords | Humans Psychoses, substance-induced Receptors, n-methyl-d-aspartate Magnetic resonance imaging Bayes theorem Double-blind method Learning Conditioning, classical Psychotic disorders Adult Female |
| Key points | Bayesian model comparison indicated that in an unstable environment reinforcement learning parameters are downregulated depending on confidence level, an adaptive mechanism the authors report was specifically disrupted by ketamine. Drug effects were underpinned by altered neural activity in a fronto-parietal network reflecting the confidence-based shift to exploitation of learned contingencies. The authors suggest an early characteristic of psychosis lies in persistent doubt that undermines stabilization of behavioral policy, resulting in failure to exploit regularities in the environment. |
Abstract
A state of pathological uncertainty about environmental regularities might represent a key step in the pathway to psychotic illness. Early psychosis can be investigated in healthy volunteers under ketamine, an NMDA receptor antagonist. Here, we explored the effects of ketamine on contingency learning using a placebo-controlled, double-blind, crossover design. During functional magnetic resonance imaging, participants performed an instrumental learning task, in which cue-outcome contingencies were probabilistic and reversed between blocks. Bayesian model comparison indicated that in such an unstable environment, reinforcement learning parameters are downregulated depending on confidence level, an adaptive mechanism that was specifically disrupted by ketamine administration. Drug effects were underpinned by altered neural activity in a fronto-parietal network, which reflected the confidence-based shift to exploitation of learned contingencies. Our findings suggest that an early characteristic of psychosis lies in a persistent doubt that undermines the stabilization of behavioral policy resulting in a failure to exploit regularities in the environment.
Comparable studies
Other randomized controlled trials on ketamine, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Healthy human subjects recruited from the community | 1994 | Randomized controlled trial | n = 19 |
| Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial Patients with treatment-resistant major depression experiencing a major depressive episode | 2013 | Randomized controlled trial | n = 73 |
| Remifentanil-induced Postoperative Hyperalgesia and Its Prevention with Small-dose Ketamine Patients undergoing major abdominal surgery | 2005 | Randomized controlled trial | n = 75 |
| Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder Patients with chronic PTSD related to a range of trauma exposures | 2014 | Randomized controlled trial | n = 41 |
| Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers Healthy volunteers | 2000 | Single-blind placebo-controlled study | n = 20 |
Citations in the library
Cited by 9
- Ketamine Affects Prediction Errors about Statistical Regularities: A Computational Single-Trial Analysis of the Mismatch Negativity Journal of Neuroscience June 19, 2020
- Evaluation of Early Ketamine Effects on Belief-Updating Biases in Patients With Treatment-Resistant Depression JAMA Psychiatry September 28, 2022
- Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans. Neuroscience & Biobehavioral Reviews August 1, 2025
- Distinct alterations in probabilistic reversal learning across at-risk mental state, first episode psychosis and persistent schizophrenia. Scientific Reports July 30, 2024
- Can we change depressive beliefs? Modulation of belief updating by ketamine in treatment resistant depression
and 4 more in the library
Cites 8
- Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Archives of General Psychiatry March 1, 1994
- Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. American Journal of Psychiatry 2003
- Measurement of dissociative states with the Clinician‐Administered Dissociative States Scale (CADSS) Journal of Traumatic Stress 1998
- The Computational Anatomy of Psychosis Frontiers in Psychiatry April 25, 2013
- Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia. Schizophrenia Bulletin September 1, 2012
and 3 more in the library